124 related articles for article (PubMed ID: 3408252)
21. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and clinical evaluation of patients with T2 gastric cancer.
Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of perinodal extension in gastric cancer.
Choi WH; Kim S; Shen J; Cheong JH; Hyung WJ; Kim YI; Choi SH; Noh SH; Park CI
J Surg Oncol; 2007 Jun; 95(7):540-5. PubMed ID: 17252555
[TBL] [Abstract][Full Text] [Related]
24. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
[TBL] [Abstract][Full Text] [Related]
25. [Benefit of screening for gastric cancer--a comparison of symptomatic and screened patients who underwent gastrectomy].
Kobayashi O; Sugiyama Y; Konishi K; Kanari M; Cho H; Tsuburaya A; Sairenji M; Motohashi H; Yoshikawa T
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1753-8. PubMed ID: 12402425
[TBL] [Abstract][Full Text] [Related]
26. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
[TBL] [Abstract][Full Text] [Related]
27. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].
Wu T; Wan YL; Rong L; Pan YS; Wang X; Liu YC
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1474-7. PubMed ID: 17785085
[TBL] [Abstract][Full Text] [Related]
29. Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer.
Deng JY; Liang H; Sun D; Pan Y; Zhang RP; Wang BG; Zhan HJ
Eur J Surg Oncol; 2009 Aug; 35(8):814-9. PubMed ID: 19111430
[TBL] [Abstract][Full Text] [Related]
30. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
[TBL] [Abstract][Full Text] [Related]
31. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
32. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer.
Inada T; Ogata Y; Kubota T; Ishihara M; Tomikawa M; Ando J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
Anticancer Res; 2002; 22(1A):291-4. PubMed ID: 12017305
[TBL] [Abstract][Full Text] [Related]
33. Combined resection of the involved organs in T4 gastric cancer.
Kitamura K; Tani N; Koike H; Nishida S; Ichikawa D; Taniguchi H; Hagiwara A; Yamagishi H
Hepatogastroenterology; 2000; 47(36):1769-72. PubMed ID: 11149053
[TBL] [Abstract][Full Text] [Related]
34. [Multi-variate analysis of prognostic factors in gastric cancer with Cox' proportional hazard model].
Nakajima T; Ota K; Ishihara S; Wakabayashi K; Nishi M
Gan To Kagaku Ryoho; 1994 Aug; 21(11):1768-74. PubMed ID: 8080294
[TBL] [Abstract][Full Text] [Related]
35. The value of D1 lymphadenectomy as prognostic marker in gastric cancer.
Diaz de Liaño A; Ciga MA; Oteiza F; Aizcorbe M; Cobo F; Trujillo R; Nuin MA
Hepatogastroenterology; 2001; 48(39):895-8. PubMed ID: 11462951
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.
Hyung WJ; Noh SH; Yoo CH; Huh JH; Shin DW; Lah KH; Lee JH; Choi SH; Min JS
World J Surg; 2002 Mar; 26(3):323-9. PubMed ID: 11865369
[TBL] [Abstract][Full Text] [Related]
37. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
38. The prognosis of stage IV gastric carcinoma patients after curative resection.
Lee JH; Noh SH; Lah KH; Choi SH; Min JS
Hepatogastroenterology; 2001; 48(42):1802-5. PubMed ID: 11813628
[TBL] [Abstract][Full Text] [Related]
39. Relevance of lymph node metastasis along the superior mesenteric vein in gastric cancer.
An JY; Pak KH; Inaba K; Cheong JH; Hyung WJ; Noh SH
Br J Surg; 2011 May; 98(5):667-72. PubMed ID: 21294111
[TBL] [Abstract][Full Text] [Related]
40. Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer.
Li C; Yan M; Chen J; Xiang M; Zhu ZG; Lin YZ
J Surg Oncol; 2009 May; 99(6):324-8. PubMed ID: 19204941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
